Penta-O-galloyl-β-d-glucose for COVID-19

 Penta-O-galloyl-β-d-glucose has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed Penta-O-galloyl-β-d-glucose in detail.
Zhu et al., Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening, ACS Pharmacology & Translational Science, doi:10.1021/acsptsci.0c00108